Production (Stage)
Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | 15.81% | 20.29% | 20.47% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 15.81% | 20.29% | 20.47% | |
| Cost of Revenue | -- | 16.81% | 21.00% | 21.10% | |
| Gross Profit | -- | 13.55% | 18.66% | 19.04% | |
| SG&A Expenses | -- | 13.96% | 17.92% | 17.01% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -114.67% | -138.23% | -105.97% | |
| Total Operating Expenses | -- | 15.80% | 19.57% | 19.67% | |
| Operating Income | -- | 16.17% | 36.02% | 38.06% | |
| Income Before Tax | -- | 18.40% | 40.79% | 42.41% | |
| Income Tax Expenses | -- | 47.67% | -8.28% | -20.84% | |
| Earnings from Continuing Operations | -- | 2.01% | 118.01% | 154.30% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | 2.01% | 118.01% | 154.30% | |
| EBIT | -- | 16.17% | 36.02% | 38.06% | |
| EBITDA | -- | 8.56% | 18.39% | 20.61% | |
| EPS Basic | -- | 1.85% | 116.87% | 153.59% | |
| Normalized Basic EPS | -- | 19.62% | 42.48% | 42.48% | |
| EPS Diluted | -- | 1.85% | 116.87% | 153.59% | |
| Normalized Diluted EPS | -- | 19.62% | 42.48% | 42.48% | |
| Average Basic Shares Outstanding | -- | 0.00% | 0.00% | 0.00% | |
| Average Diluted Shares Outstanding | -- | 0.00% | 0.00% | 0.00% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |